rdf:type |
|
lifeskim:mentions |
umls-concept:C0003873,
umls-concept:C0005522,
umls-concept:C0027540,
umls-concept:C0030705,
umls-concept:C0033860,
umls-concept:C0035452,
umls-concept:C0087111,
umls-concept:C0596227,
umls-concept:C1274040,
umls-concept:C1521761,
umls-concept:C1578536,
umls-concept:C2003941
|
pubmed:issue |
2
|
pubmed:dateCreated |
2009-1-13
|
pubmed:abstractText |
Anti-tumour necrosis factor (TNF)alpha treatments improve outcome in severe rheumatoid arthritis (RA) and are efficacious in psoriasis and psoriatic arthritis. However recent case reports describe psoriasis occurring as an adverse event in patients with RA receiving anti-TNFalpha therapy.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-10075615,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-10622295,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-12528101,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-14532144,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-14746629,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-15123038,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-15146441,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-15194567,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-15327565,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-15389187,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-15637039,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-15695305,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-15711788,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-15728381,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-15818679,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-15899052,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-15948997,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-15998792,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-16052599,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-16150791,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-16307676,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-16821276,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-16905590,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-16911391,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-17013997,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-17023816,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-17105851,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-17295430,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-17310002,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-17310003,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-17310016,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-3708236,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-7536438,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-7818570,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18385277-9550416
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor,
http://linkedlifedata.com/resource/pubmed/chemical/TNFR-Fc fusion protein,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/adalimumab,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1468-2060
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
209-15
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:18385277-Adult,
pubmed-meshheading:18385277-Aged,
pubmed-meshheading:18385277-Antibodies, Monoclonal,
pubmed-meshheading:18385277-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:18385277-Antirheumatic Agents,
pubmed-meshheading:18385277-Arthritis, Rheumatoid,
pubmed-meshheading:18385277-Female,
pubmed-meshheading:18385277-Humans,
pubmed-meshheading:18385277-Immunoglobulin G,
pubmed-meshheading:18385277-Male,
pubmed-meshheading:18385277-Middle Aged,
pubmed-meshheading:18385277-Prospective Studies,
pubmed-meshheading:18385277-Psoriasis,
pubmed-meshheading:18385277-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:18385277-Registries,
pubmed-meshheading:18385277-Tumor Necrosis Factor-alpha
|
pubmed:year |
2009
|
pubmed:articleTitle |
Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.
|
pubmed:affiliation |
ARC Epidemiology Unit, The University of Manchester, Manchester, UK.
|